untitled

Similar documents

名称未設定

untitled

Activation and Control of Electron-Transfer Reactions by Noncovalent Bond

2

(1)2004年度 日本地理


, ,

寄稿論文 規則性無機ナノ空間が創り出す新しい触媒能 | 東京化成工業


2357


センシンレンのエタノール抽出液による白血病細胞株での抗腫瘍効果の検討

1.医薬品開発forWeb.ppt


Made for Life Report 2008

Microsoft Outlook 2013



untitled

Microsoft Word - 01Ł\”ƒ.doc

FdData社会地理

消防力適正配置調査報告

QIAquick Spin プロトコールとトラブルシューティング ( /2008)

AC-2

エンジョイ北スポーツ

寄稿論文 ボロンアルドール反応の新展開 | 東京化成工業

NL10

取扱説明書

Microsoft Word - R22.1.doc

PowerPoint プレゼンテーション

untitled



untitled

1 1 H Li Be Na M g B A l C S i N P O S F He N Cl A e K Ca S c T i V C Mn Fe Co Ni Cu Zn Ga Ge As Se B K Rb S Y Z Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb T e

水素移動型不斉還元触媒|関東化学株式会社

36 th IChO : - 3 ( ) , G O O D L U C K final 1

untitled

untitled


untitled

寄稿論文 有機合成から現代の錬金術へ | 東京化成工業

HotStarTaq Plus PCRプロトコールとトラブルシューティング( /2008)

π (FMO) [4] Ligand 4 FMO FMO Gordon Schmidt (DHODH) de novo DNA RNA T. cruzi DHODH X DHODH- T. cruzi [5] DHODH DHODH FMN FMN FMNH 2 2 3

iQue_brochure

創薬と結晶構造解析-3.key

untitled

物理化学I-第12回(13).ppt

AllPrep DNA/RNA Micro プロトコールとトラブルシューティング ( /2008)

untitled

表1.eps

untitled

(1) GGT阻害剤

AriaMx PCR AriaMx PCR PCR AriaMx PCR 0.2 ml 96 6 PCR Ct SYBR Green I PCR Tm TaqMan PCR DNA HRM TaqMan AriaMx 8 Multiple Experiment Analysis PDF RDML P

30% OFF & 31 Eppendorf TC 30% OFF Cell Imaging Dishes 145/170 µm Cell Imaging Coverglasses & Slides 1/2/4/8 chamber > 2 mm 750 µl > 170 µm 145 µ

untitled

1) K. J. Laidler, "Reaction Kinetics", Vol. II, Pergamon Press, New York (1963) Chap. 1 ; P. G. Ashmore, "Catalysis and Inhibition of Chemical Reactio

寄稿論文 多環状エーテル系天然物の合成戦略 | 東京化成工業

CellKey™システムを用いた新しいGPCRの活性評価系

CARC, AIST

SCC IASCC 3 2

untitled

Poket Manual H4_H1_130306

新技術説明会 様式例


1 (1) vs. (2) (2) (a)(c) (a) (b) (c) 31 2 (a) (b) (c) LENCHAR

現場での微量分析に最適 シリーズ Spectroquant 試薬キットシリーズ 専用装置シリーズ 主な測定項目 下水 / 廃水 アンモニア 亜硝酸 硝酸 リン酸 TNP COD Cr 重金属 揮発性有機酸 陰イオン / 陽イオン界面活性剤 等 上水 / 簡易水道 残留塩素 アンモニア 鉄 マンガン

a b b c a c Ally anion type Propargyl/allenyl anion type a b c a b c a b c a b c a b c a b c b =,, or C a b c a b c b = Gothelf, K. V.; Jørgensen, K.

Key words: HIV screening kit, window period, p24antigen, enzyme-linked fluorescent assay

< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS

Studies of Foot Form for Footwear Design (Part 9) : Characteristics of the Foot Form of Young and Elder Women Based on their Sizes of Ball Joint Girth

食糧 その科学と技術 No.48( )

2013_autumn.indb

27.\..


untitled

03J_sources.key

wako_Spark_v.1.3_Aug2017_j.pdf

Precisely Designed Catalysts News Letter Vol. 5 May, 2016

untitled

研究成果報告書

H22応用物理化学演習1_濃度.ppt

24 10 QOL 6) 7) 2 8,9) Cry j 1 10,11) Cry j 2 12,13) Cha o 1 14) Cha o 2 15) Cry j 1 Cha o 1 80% Cry j 2 Cha o 2 74% T B Cry j 1 Cha o 1 IL-5 1) 1,16)

Msx2

untitled

NewsLetter-No2

都道府県別経済財政モデル(平成27年度版)_02

* 2

ADVANTAGE_Panf_p14_ ai

PCR 3 Mature mirna PCR 7 miscript mirna PCR Array C T 12 Mature mirna cdna 15 miscript mirna QC PCR Array miscript mirna PCR Array 10/2011

Untitled

U-937 Technical Data Sheet 77% HTS-RT 法 96-well plate 試薬 D 1 μl 10,000g(10,000~12,000rpm) 4 で 5 分間遠心し 上清除去 sirna 溶液 (0.23μM final conc. 10nM) 20 倍希釈した

17-05 THUNDERBIRD SYBR qpcr Mix (Code No. QPS-201, QPS-201T) TOYOBO CO., LTD. Life Science Department OSAKA JAPAN A4196K

steponeplus_bro_f-0210.indd

() () () () () 175 () Tel Fax

steponeplus_bro_f-0912.indd

untitled

寄稿論文 ナノスケールの孤独空間を有する包接化合物 ~カプセル分子~ | 東京化成工業

Transcription:

T DAC8 2011 1 27

(DAC) DAC 11 DAC8 DAC8 T Leukemia. 2008, 22, 1026 1134. Clin. Cancer. Res. 2009, 15, 91 99. DAC8 1)DAC8 2)

T T T-ALL 10 1 T-ALL 30~40% T CTCL 10 1 CTCL T ATLL 1 TLV-1 120 2,000 TLV-1 16~41% 3~13

Click Chemistry Cu(I)-catalyzed Azide Alkyne Cycloaddition (CuAAC) Angew. Chem. Int. Ed. Engl. 2002, 41, 2596 2599. CuAAC tris (benzyltriazolylmethyl)amine (TBTA) Cu(I) Cu(I) CuAAC rg. Lett.2004, 6, 2853 2855.

Alkyne, Azide-unit ZBG Alkyne-unit (A):8 Drug Design Linker Zinc-Binding Group Cap (ZBG) vorinostat (Representative DAC Inhibitor) A1 A5 2 A2 A6 2 A3 A7 2 S S A4 A8 2 Cap DAC8 Selective Inhibitor Candidates ZBG Click Chemistry Cu(I) 3 n 3 Me B1: n=1 B4:n=4 B2: n=2 B5:n=5 B3: n=3 Cap B6 B7: m- B8: p- Azide-unit (B):15 3 3 B9: m- B10: p- 3 3 3 3 B11:1- B12:2- B13 B14 B15

CuAAC Triazole Library Alkyne-unit (A):8 Azide-unit (B):15 A1 A3 A4 S A2 3 n 3 Me B1:n=1 B4:n=4 B2:n=2 B5:n=5 B3:n=3 B6 B7: m- B8: p- 3 3 B9: m- B10: p- A5 2 A7 2 A8 2 S A6 2 B11: 1- B12: 2-3 3 3 3 B13 B14 B15 TLC & LCMS Analysis CuS 4 5 2, 10 mol% Sodium Ascorbate, 50 mol% TBTA, 10 mol% DMS/ 2, rt, 1-3 days o Isolation & Purification DAC Fluorometric Assay

DAC Fluorophore C 3 DAC Fluorophore 3 + + - C 3 DEVELPER 360 nm 460 nm Detect!! DAC Activity Assay / Drug Discovery Kit, Fluorescent AK-500 (BIML TM ) DAC

PCI-34051 C10 C20 C30 C40 C50 C60 C70 C80 C90 C100 C110 C120 120 100 80 60 40 20 0 DAC8 (1) 0.3 μm Enzyme Activity (%)

PCI-34051 C10 C20 C30 C40 C50 C60 C70 C80 C90 C100 C110 C120 120 100 80 60 40 20 0 DACs (1) o Inhibition 0.3 μm Enzyme Activity (%)

C31, C32

DAC (2) Compound IC 50 (μm) a DACs class I class IIa class IIb (nuclear extract) DAC1 DAC2 DAC8 DAC4 DAC6 0.17 0.27 0.78 1.5 >10 0.21 vorinostat >100 >100 >100 0.31 >100 9.3 PCI-34051 37 41 65 0.35 30 7.9 C31 23 >100 76 0.18 >100 5.2 C32 a Values are means of at least three experiments.

DAC vorinostat C31 C32 PCI-34058 Control (2 M) (10 M) (50 M) (2 M) (10 M) (50 M) (2 M) (10 M) (50 M) (2 M) (10 M) (50 M) Ac SMC3 SMC3 Ac 3K9

Cell Line GI 50 (μm) a PCI-34051 C31 C32 Jurkat 11 11 11 MLT4F 79 68 95 T Cell >100 42 79 ut78 25 56 81 MT2 15 10 19 MT4 25 31 30 Rajii >100 >100 >100 B Cell Ramos 99 31 >100 U266 >100 42 >100 K562 >100 32 >100 Solid Tumor ela 70 87 70 ealthy PB PB- 97 >100 >100 PB- >100 82 >100 a Values are means of at least three experiments. C31, C32 T C31, C32 (PB-, ) T

C32 MacroModel 8.1, Glide 3.5 (DAC8, PDB: 1VKG) is142 Tyr306 Phe152 DAC8 Cap DAC8

Cap moiety C32 Cap C32 Lead ptimization Click Chemistry Cu(I) R C32 derivatives R 3 Azide-unit (B) A2 Azide Design & Synthesis R B16: 2-Me B17: 3-Me B18: 4-Me B19: 2-Me B20: 3-Me B21: 4-Me B22: 2-Cl B23: 3-Cl B24: 4-Cl 3 B25: 2-F B26: 3-F B27: 4-F B28: 2-CF 3 B29: 3-CF 3 B30: 4-CF 3 B31: 2-2 B32: 3-2 B33: 4-2 R B34: 1-aphtyl B35: 2-aphtyl B36: 3-Indolyl B37: 3-thienyl B38: 2-pyridinyl 3 B39: 4-methylthiazolyl B40: 4-morpholinyl B41: cyclopentyl B42: cyclohexyl B43: 1-adamantyl X 3 B44: X=SC 2 B45: X=CC 2 B46: X=CC (trans)

C32 C121 C122 C123 C124 C125 C126 C127 C128 C129 C130 C131 C132 C133 C134 C135 C136 C137 C138 C139 C140 C141 C142 C143 C144 C145 C146 C147 C148 C149 C150 C151 100 80 60 40 20 0 0.3 μm Enzyme Activity (%)

100 80 60 40 20 0 DACs (2) Enzyme Activity (%) C32 C121 C122 C123 C124 C125 C126 C127 C128 C129 C130 C131 C132 C133 C134 C135 C136 C137 C138 C139 C140 C141 C142 C143 C144 C145 C146 C147 C148 C149 C150 C151 0.3 μm

C32 C142 C149 C152, C153 A2, CuS 4 5 2, Sodium ascorbate, TBTA, Me/ 2 B44 S 3 mcpba (1.0 or 2.0 eq) C 2 Cl 2 X 3 B47: X=S,66% B48: X=S 2,97% A2 CuS 4 5 2 Sodium ascorbate TBTA Me/ 2 X C149: X=S,94% C152: X=S,70% C153: X=S 2,54%

Compound DAC (2) IC 50 (μm) a DACs class I class IIa class IIb (nuclear extaract) DAC1 DAC2 DAC8 DAC4 DAC6 23 >100 76 0.18 >100 5.2 C32 44 >100 >100 0.10 >100 1.1 C142 54 38 >100 0.070 44 2.4 C149 >100 92 >100 0.10 86 2.4 C152 C153 >100 88 >100 0.13 25 1.5 a Values are means of at least three experiments.

DAC8 PCI-34051 GI 50 (μm) C32 GI 50 (μm) C149 GI 50 (μm) T-ALL Jurkat 10.6 11.4 7.6 MLT4F 79.4 95 53.8 T-cell lines CTCL >100 79 22.9 ut78 24.7 81.2 40.1 ealthy PB ATLL MT2 15.1 19 10.6 MT4 24.8 30.1 15.4 96.6 >100 >100

DAC8 DAC8 Click Chemistry

DAC8 T / cf) TSA (DAC / /

DAC8 2010 044283